IZALTREO Trademark

Trademark Overview


On Wednesday, November 17, 2021, a trademark application was filed for IZALTREO with the United States Patent and Trademark Office. The USPTO has given the IZALTREO trademark a serial number of 97129201. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, June 16, 2025. This trademark is owned by Glaxo Group Limited. The IZALTREO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
izaltreo

General Information


Serial Number97129201
Word MarkIZALTREO
Filing DateWednesday, November 17, 2021
Status680 - APPROVED FOR PUBLICATION
Status DateMonday, June 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Saturday, November 20, 2021NEW APPLICATION ENTERED
Monday, November 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 30, 2022SUSPENSION LETTER WRITTEN
Tuesday, August 30, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, August 30, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 30, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 17, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, November 21, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, May 24, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, June 16, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 17, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED